Evidence map›Paper›PMID 24348254›Full record

ArticlePLoS pathogens2013

The malarial serine protease SUB1 plays an essential role in parasite liver stage development.

Catherine Suarez, Katrin Volkmann, Ana Rita Gomes, Oliver Billker, Michael J Blackman

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Peptidic Boronic AcidJournal of medicinal chemistry · 2024
    Article
  2. Article
  3. Peptidic boronic acids are potent cell-permeable inhibitors of the malaria parasite egress serine protease SUB1.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  4. Malaria parasite egress at a glance.Journal of cell science · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Structural Insights Into KeyFrontiers in microbiology · 2019
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Advances in molecular genetic systems in malaria.Nature reviews. Microbiology · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Catherine SuarezDivision of Parasitology, Medical Research Council National Institute for Medical Research, Mill Hill, London, United Kingdom.
Katrin VolkmannWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Ana Rita GomesWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Oliver BillkerWellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
Michael J BlackmanDivision of Parasitology, Medical Research Council National Institute for Medical Research, Mill Hill, London, United Kingdom.
Wellcome Sanger Institute · GBMedical Research Council · GB

Funding

Medical Research Council G0501670Medical Research Council MC_U117532063Medical Research Council U117532063Wellcome TrustWellcome Trust 098051
6 · The paper itself

Abstract

Transmission of the malaria parasite to its vertebrate host involves an obligatory exoerythrocytic stage in which extensive asexual replication of the parasite takes place in infected hepatocytes. The resulting liver schizont undergoes segmentation to produce thousands of daughter merozoites. These are released to initiate the blood stage life cycle, which causes all the pathology associated with the disease. Whilst elements of liver stage merozoite biology are similar to those in the much better-studied blood stage merozoites, little is known of the molecular players involved in liver stage merozoite production. To facilitate the study of liver stage biology we developed a strategy for the rapid production of complex conditional alleles by recombinase mediated engineering in Escherichia coli, which we used in combination with existing Plasmodium berghei deleter lines expressing Flp recombinase to study subtilisin-like protease 1 (SUB1), a conserved Plasmodium serine protease previously implicated in blood stage merozoite maturation and egress. We demonstrate that SUB1 is not required for the early stages of intrahepatic growth, but is essential for complete development of the liver stage schizont and for production of hepatic merozoites. Our results indicate that inhibitors of SUB1 could be used in prophylactic approaches to control or block the clinically silent pre-erythrocytic stage of the malaria parasite life cycle.

Indexed as

AnimalsAnophelesFemaleHep G2 CellsHumansLife Cycle StagesLiverMerozoitesMiceMice, Inbred C57BLOrganisms, Genetically ModifiedPlasmodium bergheiSchizontsSubtilisinsSubtilisins

Identifiers

PMID24348254
PMCPMC3861531
OpenAlexW2097247029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.